ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1429.0529900327056;7.697632086000634;0.04782911751220199;0.8417775754447168;[PRKAR1B, PRKAR2B, PKIG, SIRT1]
GO:2000481;positive regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1426.5997261217476;8.16763571524637;0.0477470089768964;0.8658135829017477;[ADRB2, SIRT1]
GO:0090335;regulation of brown fat cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;28.146757669690793;7.069023426578259;9.420466487672394E-4;0.6846304993685643;[DUSP10, PRDM16, PTGS2, MAPK14, SIRT1]
GO:1904179;positive regulation of adipose tissue development;6.0;1.0;0.8231203125901445;9.628524252492122;84.15966440839325;8.16763571524637;0.0028167482289683326;0.7408135829017477;[SIRT1]
GO:0006047;UDP-N-acetylglucosamine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;163.5767575156466;7.004484905440688;0.0054747668645245785;0.7091290490632969;[SLC35A3]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, CD40LG, MDFIC, PKN1]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[BLM, PCNA, BRCA2, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, SIRT1, POLA1, POLE2, RPA3]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, CDH5, C3AR1, CTSH, GHSR, ANXA1, ANXA3, GAB1, SIRT1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, PTGS2, DLL1, THBS1, CXCR2, PLCG1, JUP, PLK2, TNFSF12, LRG1, TEK]
GO:0048240;sperm capacitation;4.0;1.0;0.75;9.628524252492122;67.15086498286243;6.558197802812269;0.0022474790191214893;0.5853865406232063;[SLC26A8, ROPN1L, SLC26A3, CFTR]
GO:0018394;peptidyl-lysine acetylation;9.0;0.6696747006330769;0.7310779754968275;8.884083777544626;313.638027190515;5.076593261888053;0.010497182514167671;0.6558578406789737;[BRCA2, RUVBL2, RUVBL1, SIRT1, POR, TAF9, ELP4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, SLA2, PHB2, MYB, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, XCL1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, RUNX2, SFRP2, PCBP3, EGR1, BCL11A, IFNA2, PTPRK, XPO1, CD36, MDFIC, IL1B, ARID4A, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0000183;chromatin silencing at rDNA;12.0;1.0;0.9481203125901445;9.628524252492122;1754.5970941496832;7.292166977892469;0.058724785706324785;0.8210420709600095;[SIRT1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, JUN, JAG1, JUP, COL1A1, FOS, SIRT1, MMP12, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, BLM, FOXO1, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, E2F5, E2F7, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, BRCA2, CD3D, RGMA, IL1B, IL17A, CD86, CD80, CCNE1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, LBH, EMILIN1, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, BCL11B, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, SLC40A1, CKAP2, DCN, DNM2, DLL1, MEIS2, MEIS1, RBMX]
GO:0034983;peptidyl-lysine deacetylation;9.0;1.0;0.896240625180289;9.628524252492122;328.6076320466096;7.8311634786251565;0.010998201716931447;0.7967266896635242;[SIRT1]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, SIRT1]
GO:0071934;thiamine transmembrane transport;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;153.8371691668038;8.390779266560578;0.0051487916075492485;0.7522251544931926;[SLC19A2]
GO:0050434;positive regulation of viral transcription;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;62.40780878563472;6.7325511899570465;0.0020887331966737226;0.6952223462072524;[JUN, MDFIC]
GO:0070602;regulation of centromeric sister chromatid cohesion;9.0;0.811012628672052;0.801746939516315;9.34084218004034;56.72753252279278;8.390779266560578;0.0018986194620731454;0.8253454670833372;[AXIN2]
GO:0046628;positive regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;293.6040497598144;7.069023426578259;0.009826663318971241;0.7124295520356204;[SIRT1, GNAI2]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNG2, KCNE3, KCNE4, SLC1A3, KCNA5, KCNMB3, KCNN3, KCNH1, SLC12A2, KCND2, SLC12A1, KCNJ15, KCNJ16, ATP1B2, ATP1B1, KCNQ1]
GO:0044321;response to leptin;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;25.223505691001428;6.943860283624253;8.44208035796484E-4;0.6453503496879909;[PID1, SIRT1]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, SFN, BARD1, LYN, PLK2, CDKN1A, CHAF1B, CHAF1A, CTLA4, SIRT1, UNG, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, COPS5, BCL6, CNOT3, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, RBBP8, POLR2E, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, ESCO2, MIF, POLA1, BRCA2, RAD51C, SGK1, PCNA, RAD54B, RPA1, MLH1, RPA3, DCLRE1A, PSMD14, HMGA1, JMY, TOPBP1, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[HSD17B4, SCARB2, LAMP2, HGS, SLC27A2, NUP54, NLGN1, VPS41]
GO:0051097;negative regulation of helicase activity;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;49.94359093049245;8.390779266560578;0.0016715670421299067;0.7522251544931926;[SIRT1, MCM2]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[SLC11A1, AXIN2, MAPK14, MYD88]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[RANBP2, NUP35, NUP54]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[, NUP107, AKT1, SEH1L, NUP85, NUP88, JUP, COL1A1, EZH2, LRRC4, MMP12, FLNA, DMD, CSE1L, TNF, CDH1, RUVBL2, LAMP2, CD177, RAB32, PKP3, SLC27A2, LIN7A, NACC2, PLEKHF1, LRRK2, HHEX, NLGN1, TSPAN33, DNAJA3, VPS41, PAQR3, GOLPH3L, ESCO2, TSPAN5, CD24, NRP1, PTPRK, BRCA2, TRAM2, XPO1, FCER1G, SYK, RAB33B, MIS12, HSD17B4, RANBP2, RANBP1, RPA1, RAMP1, SCARB2, CELSR1, TTC7B, TSC2, ATP1B1, HGS, VCL, NUP155, CAV1, TNFAIP3, NUP62, NUP133, AXIN2, NUP54, HSPD1, NUP35, RAN]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, SIRT1, PKHD1, BANK1, AKT1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[RPA1, SIRT1, RPA3]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[TNF, PYCARD, MSH6, MELK, MSH2, LGALS12, CUL5, TP53BP2, SFN, TNFRSF10B, JMY, CD24, CDKN1A, BRCA2, TNFRSF1B, SIRT1, BCL2A1, MLH1]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, PYCARD, RHOH, SIRT1, NLRP12, CCDC22]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[TMEM64, AXIN2, TNF, MEN1]
GO:0072488;ammonium transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.193206181234276;79.759283350777;7.069023426578259;0.002669471435055758;0.7124295520356204;[SLC22A4, SLC12A2, RHCE]
GO:0097623;potassium ion export across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;138.27080336829306;8.390779266560578;0.0046277993530927835;0.8615337942327104;[KCNQ1]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[ABCA1, NFKBIA, LRP1, NR1H2, SIRT1]
GO:0015888;thiamine transport;6.0;1.0;0.8231203125901445;9.628524252492122;74.12567647986099;8.67846133901236;0.002480919683003216;0.7669372290569613;[SLC19A2]
GO:0032423;regulation of mismatch repair;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;106.94291367646407;8.67846133901236;0.0035792830783775275;0.8188169164668168;[AXIN2]
GO:0036228;protein localization to nuclear inner membrane;8.0;1.0;0.875;9.628524252492122;68.37109962721291;9.083926447120524;0.002288319174528017;0.839552420951524;[NUP155, NUP54]
GO:0042723;thiamine-containing compound metabolic process;5.0;0.811012628672052;0.6957473261969462;9.517298617381897;171.22303227662272;7.8311634786251565;0.005730680799573931;0.6907270763441554;[ACPP, SLC19A2]
GO:0035377;transepithelial water transport;6.0;1.0;0.8231203125901445;9.628524252492122;37.816033014382604;9.083926447120524;0.0012656685927712316;0.7876727335416686;[CFTR]
GO:0060372;regulation of atrial cardiac muscle cell membrane repolarization;9.0;0.8653626801206646;0.8289219652406215;9.474373572664863;48.25689803028158;7.8311634786251565;0.001615114948684907;0.7967266896635242;[KCNQ1, FLNA, KCNA5]
GO:0045795;positive regulation of cell volume;7.0;1.0;0.8509193652572005;9.628524252492122;50.63290440139966;9.777073627680469;0.001694637743659323;0.8509193652572005;[SLC12A2]
GO:0000720;pyrimidine dimer repair by nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;368.1807062307652;8.67846133901236;0.012322676896420592;0.8400575416471059;[SIRT1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKAR1B, FPR1, FPR2, SLC30A10, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, LYN, JUN, ACE, FZD5, CDC6, AZU1, NOX4, EZH2, CDKN1A, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, HBEGF, ENG, CCL13, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL20, CARD9, PKN1, CCNT2, FMR1, TNF, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, F2R, ADAM9, IFNA10, TNFRSF11A, DRD4, IFNA21, MAP2K6, TNFRSF10B, PTPRC, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, XCL1, LCP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, CCNH, TCL1A, EDNRB, TNFSF11, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, SFRP2, EPHA3, TGFA, CCR1, EGR1, PTK2, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, SYK, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD40LG, CD80, IL6R, PDGFRB, CALCA, C5AR1, ADRB2, STAP1, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, GHR, GRM5, AXIN2, MMP9, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, EGF, MAPK14, CD4, LTBR, TEK]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ITGB3, HMGB2, AKT1, PLCG1, GHSR, JUN, EGR3, ARG1, CAV2, TNFSF12, SIRT1, NR4A1, LRG1, CXCL12, AGTR1, TEK]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[PPP2R1A, RUVBL2, RUVBL1, TLE4, TSC2, SFRP2, NAIP, APCDD1, FOXO1, EGR1, JUP, FZD5, CAV1, NFKB1, COL1A1, CDK14, LRRK2, TNFAIP3, HHEX, AXIN2, AES, MDFIC, PFDN5, TLR2, LRP1, CTHRC1, EGF, TMEM64, MAPK14, PPP1CA, SULF2, LGR4]
GO:0070857;regulation of bile acid biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;200.7778490682047;7.474488534686424;0.0067198539199799295;0.7572456912631272;[SIRT1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, JMY]
GO:0010460;positive regulation of heart rate;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.35920462208708;6.641579411751319;0.003158117660930423;0.7146506799819907;[GCH1, KCNQ1, TPM1, TACR3, AVPR1A]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, CDH5, FOS, SIRT1, TGFBR3, ADAM9, JUN, TGFB2, TGFB1, USP9Y, PTK2, ZYX]
GO:0003376;sphingosine-1-phosphate signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;50.14720301582843;7.292166977892469;0.001678381755387122;0.6960420709600095;[SPNS3, SPNS1, S1PR3, GPR6, S1PR5]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[NLGN1, NUP54]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0006642;triglyceride mobilization;8.0;1.0;0.875;9.628524252492122;86.98015092181912;8.390779266560578;0.0029111473742996327;0.8041048419030481;[SIRT1]
GO:0050872;white fat cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.292166977892469;7.282666309192915E-4;0.6631627702307852;[PRDM16, SIRT1]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[TFRC, SLC40A1, HEPH, SLC11A1, CYBRD1, LCN2, LTF]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[SIRT1, PPP1CA, MC3R, LGR4]
GO:0006999;nuclear pore organization;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;38.430292282043744;7.069023426578259;0.0012862272976623997;0.6517511986393402;[NUP205, AHCTF1, SEH1L, NUP107, NUP133, NUP35, NUP54]
GO:1990569;UDP-N-acetylglucosamine transmembrane transport;8.0;1.0;0.875;9.628524252492122;142.06452249237992;9.083926447120524;0.004754771718050423;0.839552420951524;[SLC35A3]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[MPL, PHB2, SLC8A1, AKT1, KCND2, SIRT1, PTGS2]
GO:0032007;negative regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;5.926926025970411;0.008015432820232688;0.6781032725983739;[TSC2, SIRT1, SIK1]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, SIRT1]
GO:0070914;UV-damage excision repair;8.0;1.0;0.875;9.628524252492122;251.03601357316452;7.292166977892469;0.008401949456549422;0.747921758369865;[SIRT1]
GO:0033210;leptin-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;30.19135422731818;7.57984905034425;0.00101047745553359;0.738553198190834;[SIRT1]
GO:0031393;negative regulation of prostaglandin biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;814.0923329901884;9.083926447120524;0.02724693774964864;0.8797934328124444;[SIRT1]
GO:0061647;histone H3-K9 modification;8.0;0.8436909121759173;0.7968454560879586;9.488762310116963;187.05115224840347;7.138016298065211;0.0062604337306462815;0.7400384854347593;[EHMT2, ARID4A, ARID4B, SIRT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, JUP, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[NUP107, HHEX, NUP62, MAGOH, NUP133, NUP54, SLBP, NUP205, SEH1L, NUP160, NUP85, NUP43, NUP88, RANBP2, NUP155, NUP35, NUPL2, NUP37]
GO:0010906;regulation of glucose metabolic process;7.0;0.6763753087927167;0.6891070196535589;8.753055515138222;59.50955823828417;5.171903441692378;0.00199173135911005;0.615410747783455;[AKT1, DGAT2, SIRT1, SIK1, FBP1, FOXO1, SORBS1, PPP1CA]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[AXIN2, DLL1]
GO:0071441;negative regulation of histone H3-K14 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1489.6293825007795;9.777073627680469;0.04985655485289462;0.9481203125901445;[SIRT1]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[PTAFR, AQP9, SLC8A1, KCNQ1, NOX4, SLC26A3, CFTR]
GO:0061092;positive regulation of phospholipid translocation;9.0;1.0;0.896240625180289;9.628524252492122;348.31453857334856;8.67846133901236;0.011657774143316984;0.8400575416471059;[ATP8A1, ABCB4]
GO:0010107;potassium ion import;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;6.063501560976162;0.004073929841064025;0.7253287636709003;[SLC12A2, SLC12A1, KCNJ15, KCNJ16, ATP1B2, ATP1B1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, BARD1, HACE1, SIRT1, FBXW2, CUL5, MARCH3, MARCH1, NLRC4, RNF24, SKP2, NAIP, PCNA, KLHL14, UBE2M, TNFAIP3, HIST1H2BK]
GO:1900113;negative regulation of histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;912.0848673078575;8.390779266560578;0.03052665968570576;0.8772251544931927;[SIRT1]
GO:0042595;behavioral response to starvation;6.0;1.0;0.8231203125901445;9.628524252492122;23.524030502816238;9.083926447120524;7.873281306762962E-4;0.7876727335416686;[SIRT1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[SKP2, ESCO2, SPARCL1, SDC2, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, FBXW2, PSMD14, CUL5, IGFBP7, NAE1, WFS1, COPS5, CCDC22, UBE2M, LAMB1]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, AXIN2, RUVBL1, MEN1]
GO:2000619;negative regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1675.3938874144621;8.67846133901236;0.056073925655155225;0.9063718812344532;[SIRT1]
GO:0050892;intestinal absorption;4.0;0.811012628672052;0.655506314336026;9.176539128749065;23.07461412231494;6.375876246018314;7.722865688694012E-4;0.576062607729944;[MOGAT2, ABCB4, KCNQ1, CD36]
GO:0043570;maintenance of DNA repeat elements;7.0;0.811012628672052;0.7564256795932265;9.446202695698167;170.28329447847625;8.16763571524637;0.005699228621179078;0.7686126355688037;[MSH6, MSH2, AXIN2]
GO:0050891;multicellular organismal water homeostasis;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;44.18128547502974;5.682729065458369;0.001478707864273793;0.6137353412716126;[PRKAR2B, STMN1, SFN, PRKACB, WFS1, CYP4F2, CLDN4, ADCY9, PRKAR1B, CFTR]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, DBF4, CCNE1, MCM3, MCM4, RHOU, MCM6, MCM2, CUL5, PRIM1, IQGAP3, RBBP8, RANBP2, RANBP1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, NASP, POLE2, RPA3]
GO:0031937;positive regulation of chromatin silencing;11.0;0.8259837884571596;0.845420846558242;9.478992518521158;424.62505234881525;7.697632086000634;0.014211818364378214;0.8260862151842345;[SIRT1]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, KCNG2, FMR1, SLC8A1, AKT1, SCN1A, KCNH1, MEF2C, F2R, CACNA2D3, ACTN4, ATP1B2, ATP1B1, GEM, KCNQ1, CFTR, KCNE3, KCNE4, HVCN1, ADRB2, CACNA1F, CORO1A, CD19, PLCG1, SCN3A, DRD4, LYN, TGFB1, CAV1, CXCL10, CXCL11, FXYD6, KCNK5, CXCL9, CTSS, GRM5, JPH2, PDE4B, KCND2, TRPC1, MMP9, DNM2, TMEM37, XCL1, NLGN1, PTAFR, KCNA5, THBS1, PLN, FLNA, DMD, FYN, KCNJ15, KCNJ16, TSPAN13, GOPC, PTPN6, F2RL3]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[CDKN1A, BLM, FIGNL1, EGR1, TGFB1, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4]
GO:0098914;membrane repolarization during atrial cardiac muscle cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;124.80295429285788;8.16763571524637;0.00417704256481522;0.8139338954918922;[KCNQ1, KCNA5]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL20, MAPK14, NFKB1, COL1A1]
GO:0098915;membrane repolarization during ventricular cardiac muscle cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;124.80295429285788;7.697632086000634;0.00417704256481522;0.7898978880348613;[KCNQ1]
GO:0060452;positive regulation of cardiac muscle contraction;9.0;0.811012628672052;0.801746939516315;9.466005322994347;171.4016794204555;7.379178354882098;0.005736659958706022;0.7736121494158466;[KCNQ1, CTGF]
GO:0060453;regulation of gastric acid secretion;6.0;0.8259837884571596;0.7361122068187242;9.427853557029971;33.403759553966054;7.379178354882098;0.0011179937708393987;0.7004918368257019;[KCNQ1, SGK1]
GO:0090400;stress-induced premature senescence;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;55.82928668984125;7.697632086000634;0.0018685559824130236;0.6838982747154925;[CDKN1A, MAPK14, SIRT1]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[AKT1, MEF2C, F2R, MSH2, NAIP, C5AR1, SLC30A10, CORO1A, JUN, WFS1, NR4A2, NRP1, LRRK2, CHL1, SIRT1, LRP1, GPNMB, NTF3, CCL2, FYN, GABRA5]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, SKP2, HACE1, TGFB1I1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, RANBP2, RANBP1, USP9Y, PSMC6, PSMC2, PSMD14, CUL5, WFS1, RNF24]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, ATP1B1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, SFRP2, PFDN5, FOXO1, CTHRC1, EGR1, CAV1, TMEM64, MAPK14]
GO:0002821;positive regulation of adaptive immune response;6.0;0.6162540371078848;0.6312473311440869;8.312847458586184;108.8065326900253;5.202362649177086;0.0036416567296131998;0.5891693804036648;[TFRC, CD80, TNF, TNFSF13B, PYCARD, IL6R, CCR2, ANXA1, FCER1G, SLC11A1, SIRT1, MSH6, FCER2, MSH2, IL1B, BTK, XCL1, PRKCQ, CD274, CD1E, CD1B, CD1A, UNG, HSPD1, NLRP3, CCL19, IL12RB1, TGFB1, FZD5, MLH1, CD4, CD28]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC24A2, SLC24A1, SLC24A4, SLC8A1, SCN3A, SLC17A3, SCN1A, SLC13A1, SLC12A2, SLC6A16, SLC6A15, SLC12A1, SLC6A13, ATP1B2, ATP1B1, SLC6A6, CAPS2]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CCL5, PDGFD, PDGFC, FYN, PDGFRB, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, GH1, KIT, CD28, PTPN6, TEK]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[CDKN1A, BRCA2, SIRT1, PYCARD, MSH2]
GO:0060766;negative regulation of androgen receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;234.23542340630428;7.292166977892469;0.007839648823214116;0.747921758369865;[SIRT1]
GO:0045921;positive regulation of exocytosis;8.0;0.6913464685778243;0.7206732342889122;8.870838550794605;171.96353606350112;5.407625775213448;0.00575546479491061;0.6515462336247315;[ITGAM, CD177, FCER1G, SYK, FGR, IFNG, HGS, CFTR, NLGN1, PTAFR, SDC1]
GO:0001542;ovulation from ovarian follicle;4.0;1.0;0.75;9.628524252492122;27.16069640012757;7.697632086000634;9.090440654724862E-4;0.6436572628545723;[ADAMTS1, SIRT1]
GO:0010934;macrophage cytokine production;5.0;1.0;0.7902410118609202;9.628524252492122;22.637273805675832;9.083926447120524;7.576491820522217E-4;0.7547934328124444;[SIRT1]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, TNR, DCC, SIRT1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, BCL6, SIPA1]
GO:0061181;regulation of chondrocyte development;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;87.86935712531108;8.67846133901236;0.0029409083056968813;0.7947362817240173;[AXIN2]
GO:0030301;cholesterol transport;7.0;0.7763722522362496;0.7391054913753253;8.999915593069748;37.84975072563126;5.845247994956144;0.0012667970942227542;0.6498456195510879;[ABCA1, MSR1, CAV1, CD36, CFTR]
GO:0070208;protein heterotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;7.212124270218933;0.002859955186148837;0.7197477358342742;[COL1A1, NUP62, NUP54]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[SLC4A3, SLC4A7, CA4, SLC26A8, SLC26A7, SLC26A3, CFTR]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[ADRB2, TSC2, SIRT1, DCN]
GO:0042306;regulation of protein import into nucleus;8.0;0.8259837884571596;0.7879918942285797;9.510741216835738;189.4811146876517;5.618190544320798;0.006341762386663705;0.6623145257091445;[CDKN1A, LRRK2, PTGS2, CDH1, NUP62, CD36, TGFB1, JUP, MAPK14, SIRT1, IFNG, MDFIC, NUP54, PKIG]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[MIF, SIRT1]
GO:1902161;positive regulation of cyclic nucleotide-gated ion channel activity;9.0;1.0;0.896240625180289;9.628524252492122;311.94749038650826;9.777073627680469;0.010440601768721912;0.896240625180289;[CFTR]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[MDFIC, CD36, PKIG]
GO:0055064;chloride ion homeostasis;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;35.39315814371355;7.212124270218933;0.0011845771512957555;0.7438283705770736;[SLC12A2, SLC12A1, FASLG]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A3, PHB2, SCN1A, SLC6A16, SLC11A1, SLC6A15, CACNA2D3, SLC6A13, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, ATP5J, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, KCNN3, SCN3A, ABCA1, SLC6A6, FXYD6, GABRB1, COX7B, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, CLDN17, SGK1, CAPS2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A3, GABRA5, COX6C, KCNG2, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, SLC16A3, KCNH1, CHRNB4, SLC38A1, F2R, ATP11C, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, CACNA1F, SLC1A6, SLC38A6, CYC1, CLCA4, GRIA4, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[TAF9, MIF, SIRT1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, BLM, MGST1, CD79B, CD79A, NACC2, VASP, CAV1, CD3G, CD3E, CD3D, ALAD, EMILIN1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[DHCR24, CFTR]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[, ACSL1, ACSL5, ELOVL6, ACSBG1, SLC27A2, HSD17B4, PTGS2, ALOX5, PNPLA8, CYP4F2, CYP4F3, TBXAS1, PLP1]
GO:0001678;cellular glucose homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;49.180086311476984;5.514393750639154;0.0016460132296410052;0.6329257181104212;[FOXO1, HK3, MEN1, SIRT1, PAX2, LIN28A, IL1B, NOX4]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, HOXA5, MEF2C, ATF3, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CDKN1A, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, FOS, SIRT1, DUSP6, AES, PTGS2, FGD3, FGD4, GSN, BIK, G0S2, HP, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, ITGAM, PLEKHF1, LRRK2, FASLG, LCK, LRP1, NLRC4, CCL5, CCL2, FYN, P2RX1, MNDA, FCGR2B, PPP2R1A, SFRP2, SIK1, INPP5D, TP53BP2, EGR1, TNFSF12, ITM2C, CTSH, CD36, VAV1, IL1B, TLR6, TLR4, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, PDGFRB, KMO, NLRP3, TGFB2, TGFB1, CAV1, INHBA, EIF2S1, JMY, UBE2M, AXIN2, MMP9, DNM2, IFNG, BCL2A1, THBS1, HSPD1, CNR1, HSPE1, LTBR]
GO:0055075;potassium ion homeostasis;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;71.74727346628734;6.409777797693995;0.0024013166745626502;0.7027963346592216;[SLC12A2, SLC12A1, KCNA5, ATP1B2, ATP1B1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, EPHB1, MEF2C, SFRP2, SPINT1, BTK, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, HGS, CD274, CUL5, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, CD9, PTPN6, MNDA, FCGR2B]
GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.600353375525426;999.3623287810346;6.781341354126479;0.033447757776597226;0.7620391240755716;[SIRT1, VNN1, AKT1]
GO:0055078;sodium ion homeostasis;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;71.74727346628734;6.343086423195323;0.0024013166745626502;0.6993857346658935;[SLC12A2, MC3R, CYP4F2, SLC12A1, ATP1B2, ATP1B1, SLC8A1]
GO:0060307;regulation of ventricular cardiac muscle cell membrane repolarization;9.0;0.811012628672052;0.801746939516315;9.474373572664863;48.25689803028158;6.781341354126479;0.001615114948684907;0.7430387373949403;[KCNE3, KCNQ1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, NKX2-3, JUN, JAG1, JUP, FZD5, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, HHEX, PPP1R12A, CHUK, CEBPE, ABLIM3, E2F5, E2F7, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, MAPK14, MEIS2, MEIS1, RBMX]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, FASLG, PHB2, SLC8A1, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, F2R, CACNA2D3, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, CUL5, ATP2C2, CACNA1F, CCL19, PTPRC]
GO:2000774;positive regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.05173707047635;7.474488534686424;0.005490664002770884;0.7331650565203278;[HMGA1, PAWR, SIRT1]
GO:2000655;negative regulation of cellular response to testosterone stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;79.37071810283105;9.777073627680469;0.0026564665058930264;0.7902410118609202;[SIRT1]
GO:0035774;positive regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1297.4197001833559;6.375876246018314;0.043423469763213894;0.7584915600596062;[CFTR]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[PTPRR, CUL5, EGF, GAB1, BTC, HBEGF]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[BCL6, PLK2, SLC30A10, SIRT1]
GO:0016458;gene silencing;7.0;0.6835726970475526;0.6927057137809769;8.659123695304018;69.21166146355857;4.8942717050940985;0.002316452022733967;0.6012126478626229;[FMR1, SIRT1, KCNQ1, CNOT3]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[RUVBL1, SKP2, CFTR, PSMD14, ADRB2, NLRP3, BARD1, NFKBIA, COPS5, TNFAIP3, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[DGAT2, POLD1, SIRT1]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[CDKN1A, PLEKHF1, EHMT2, LRRK2, LAMP2, UPP1, SIRT1, SIK1, ATF3, SEH1L, FOXO1, GAS2L1, JUN, EIF2S1]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, PTGS2, THBS1, AKT1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, SIRT1, CXCL10, ITGA7, COL6A3, HBEGF]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, TNFSF11, TLE4, SIRT1, PADI2, BSPRY, KLF5]
GO:0051152;positive regulation of smooth muscle cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;145.28799013580416;7.292166977892469;0.004862658279143298;0.7238411236270654;[MYOCD, TGFB1, SMARCD3, KIT, SIRT1, ENG]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[TGFB1I1, PRDM16, EMILIN1, TGFB1, CAV2, CAV1, SIRT1, DNM2, TGFBR3]
GO:1901381;positive regulation of potassium ion transmembrane transport;9.0;0.7369933605727446;0.7647373054666613;9.271849308553389;341.4877247401287;6.311337724880743;0.01142928682805268;0.7190027299379095;[KCNQ1, FLNA, ATP1B2, ATP1B1, DNM2]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[GABRB1, SLC1A3, GABRE, CLCA4, SLC12A2, GABRA5, SLC12A1, CLDN4, SLC26A8, SLC26A7, CLDN17, SLC26A3, CFTR]
GO:1902237;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;829.3805359816347;7.292166977892469;0.027758620145282933;0.7881627702307852;[SIRT1, ATF3]
GO:1902358;sulfate transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;123.29733532969695;7.069023426578259;0.0041266508530873195;0.7365101867784198;[SLC13A1, SLC26A8, SLC26A7, SLC26A3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA7, HOXA5, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[FBL, SIRT1, NOP56]
GO:0007214;gamma-aminobutyric acid signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.558197802812269;9.028936615729279E-4;0.6585068532133508;[SLC12A2, GABBR1, GABRB1, GABRA5, GABRE, GNAI2]
GO:0045332;phospholipid translocation;8.0;1.0;0.875;9.628524252492122;116.86638763413639;6.641579411751319;0.003911412821194078;0.7146506799819907;[ABCA1, ATP8B4, ATP8A1, ABCB4, ATP11C, ATP9A]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, TLE4, HOXB9, SFRP2, CCNE1, PFN1, APCDD1, FZD5, NR4A2, VANGL1, SDC1, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, CTHRC1, EGF, TMEM64, LGR4]
GO:0035356;cellular triglyceride homeostasis;8.0;1.0;0.875;9.628524252492122;50.566380672597894;7.8311634786251565;0.001692411254323797;0.7754860644832351;[DGAT2, SIRT1]
GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.212124270218933;0.0014007232725606145;0.6919486831672181;[SIRT1]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CEBPE, MMP9, SIRT1, NKX2-3]
GO:0015884;folic acid transport;9.0;0.8436909121759173;0.8180860812682478;9.466005322994347;145.05983975507982;7.697632086000634;0.004855022291222466;0.7898978880348613;[FOLR3, LRP2, SLC19A2]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, HAVCR2, CHUK, IRAK3, SIRT1, PKHD1, NLRP3, NFKBIA, NLRP12, CCDC22]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[LRRK2, RUVBL1, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP2, LGR4, NAIP]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, NCKAP1L]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[FASLG, TNF, CTGF, PYCARD, CTSH, F2R, SIRT1, LCK, S100A8, NLRC4, HSPD1, NLRP3, GSN, TNFRSF10B, HSPE1, NLRP12, P2RX1]
GO:0003413;chondrocyte differentiation involved in endochondral bone morphogenesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.7079342821725234;[AXIN2]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, SKP2, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, PSMD14, WFS1, RNF24]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, SIRT1]
GO:0051454;intracellular pH elevation;11.0;0.8436909121759173;0.8542744084176208;9.481920778300246;181.15151768737684;7.9853141584524145;0.006062978271215114;0.8407982897480031;[SLC26A3, CFTR]
GO:0002329;pre-B cell differentiation;8.0;1.0;0.875;9.628524252492122;65.74174033395262;9.083926447120524;0.002200316885252328;0.839552420951524;[ATP11C]
GO:1990619;histone H3-K9 deacetylation;11.0;1.0;0.9324289523296623;9.628524252492122;359.8035512049472;9.083926447120524;0.012042301056656516;0.8969813732811862;[SIRT1]
GO:0070634;transepithelial ammonium transport;7.0;1.0;0.8509193652572005;9.628524252492122;45.514515802263766;8.67846133901236;0.001523329883496921;0.7947362817240173;[SLC12A2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, COL1A1, NOX4, NRP1, NRP2, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB2, TGFB1, CXCL10, CXCL11, CXCL12, PTPRC, DOCK5, CXCL6, CXCL9, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0032071;regulation of endodeoxyribonuclease activity;8.0;0.7436939687323844;0.7468469843661922;9.310070521373587;159.39497753169505;7.697632086000634;0.0053348064518193685;0.7686572628545723;[AKT1, SIRT1]
GO:0006343;establishment of chromatin silencing;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.24116723228514;9.777073627680469;7.10922751455178E-4;0.7902410118609202;[SIRT1]
GO:0006344;maintenance of chromatin silencing;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.24116723228514;8.390779266560578;7.10922751455178E-4;0.7193458537639684;[SIRT1]
GO:0045348;positive regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[CIITA, AZU1, SIRT1]
GO:0006346;methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1936.9706715625437;7.212124270218933;0.06482866521676948;0.8169486831672182;[SIRT1]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, IL1B, EZH2, ENG]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CD36, IL1B, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, AKT1, GHSR, SIRT1, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0071872;cellular response to epinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;7.212124270218933;0.01373211325256535;0.7438283705770736;[KCNQ1, PDE4B]
GO:0035338;long-chain fatty-acyl-CoA biosynthetic process;8.0;1.0;0.875;9.628524252492122;500.3176215265477;6.8867018697843045;0.016745180535867314;0.7271862538851576;[ACSL1, TECR, ACSL5, ELOVL6, ACSBG1]
GO:0033158;regulation of protein import into nucleus, translocation;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;190.5797269763205;6.943860283624253;0.006378531951278581;0.7513499630073597;[CDKN1A, IFNG, LRRK2, SIRT1]
GO:0030321;transepithelial chloride transport;8.0;1.0;0.875;9.628524252492122;29.941547406775403;8.16763571524637;0.001002116646061566;0.7926932703116032;[SLC12A2, P2RY6]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, IL18RAP, PDGFD, MYB, ANXA1, ARG1, SIRT1, PAX2, EZH2]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPIB, MEF2A, MEF2C, PADI4, ATF3, JUN, HACE1, EZH2, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, NFKB1, CIITA, FASLG, HHEX, E2F5, E2F7, POU2AF1, CCNH, UXT, BTK, ZNF700, EGR1, EGR2, EGR3, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, EBF1, NHLH2, BCL11B, BCL11A, MDFIC, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, C5AR1, NLRP3, CBX4, NR4A2, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[TFRC, FMR1, TNF, SLC8A1, IL18RAP, CDH1, MYB, MEF2C, KCNQ1, CFTR, BLM, ABCB4, FOXO1, PDGFD, EGR1, TGFB1, JUP, NFKB1, EZH2, LRRK2, TNFAIP3, PTPN22, PDE4B, MAP4K1, ANXA1, PPP1R12A, ARG1, SIRT1, PAX2, DNM2, IL1B, FBP1, PCNA, PTAFR, PTGS2, GNAI1, CCL7, FYN, RAD51, CD69]
GO:1904322;cellular response to forskolin;6.0;1.0;0.8231203125901445;9.628524252492122;399.34918558873596;7.379178354882098;0.013365857850721597;0.7004918368257019;[GNAI1, CFTR]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, TNF, FOXO1, TGFB1, JAG1, SORT1, SIRT1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SLA2, SPIB, AKT1, ATF3, JUN, JAG1, JUP, PKIG, CHAF1B, FOS, MMP12, MED23, PTAFR, ZNF467, ATAD2, PKN1, LGR4, GMNN, EFEMP1, BLM, CIITA, HHEX, E2F5, E2F7, POU2AF1, SMARCAL1, TNFSF11, FBXO5, BTK, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, SYK, IL1B, KIT, PCNA, NR3C2, CARD11, CAV1, TCF4, MXD1, TNFAIP3, MYOCD, NUP133, IRAK3, ELF3, FBP1, CD4, PHB2, PRKCQ, NUP85, PRDM16, NFE2, CDKN1A, ZNF367, EPCAM, NR1H2, ELP4, PF4, PLXND1, TNF, TLE4, MAP2K2, MAP2K6, COPS5, BCL6, CCDC22, SLC26A3, LBH, EMILIN1, RFC1, XCL1, CEBPE, NLRC4, ABLIM3, POLR2K, POLR2L, DNAJA3, PPIL4, PPP2R1A, RPS6KA1, FLT3LG, SIK1, AHCTF1, IFNA2, PRL, XPO1, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, GRHL2, CD40LG, HOXA11, HOXA10, NLRP3, CBX4, KDM5D, SLC40A1, DCN, DNM2, PFDN5, LTF, RBMX, PID1, EHMT2, MEF2A, MEF2C, PADI2, PADI4, HACE1, COL1A1, EZH2, SIRT1, PSMA6, BTAF1, STAT4, FLNA, USP9Y, PSMC6, PSMC2, CCNT2, RUVBL2, RUVBL1, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, CXCL10, MYD88, FASLG, PPP1R12A, BDP1, LRP2, CCNH, UXT, TMPO, SFRP2, PCBP3, ZNF700, OR7D2, CD28, PTPRK, BRCA2, PCSK6, CD3D, CD36, RGMA, NLRP12, IL17A, CD86, CD80, CCNE1, CALCA, HMGA1, INHBA, HMGB2, ARHGEF10L, AFF3, NUP62, PSRC1, CREB5, TAF9, EGF, MAPK14, NUP35, RAN, EHF, HOXA9, MYB, HOXA3, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ELANE, NKX2-3, FZD5, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, ENG, GTF2H1, PYCARD, DACH1, CDH1, MEN1, F2R, NACC2, WFS1, HOPX, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, KLF1, KLF8, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, BCL11B, BCL11A, RHOG, RHOH, MDFIC, SGK1, LILRB1, CAMK4, ARID4A, ARID4B, CHCHD3, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, JMY, CREBZF, TMEM100, CKAP2, TGFBR3, IFNG, DLL1, HSPD1, MEIS2, MEIS1]
GO:1902943;positive regulation of voltage-gated chloride channel activity;10.0;1.0;0.9152410118609203;9.628524252492122;1152.1971065561047;9.083926447120524;0.03856300024635883;0.8797934328124444;[PTAFR, CFTR]
GO:0000012;single strand break repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;7.474488534686424;0.006126539929698291;0.7572456912631272;[SIRT1]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[KCNQ1, ARID4A, ARID4B]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[STXBP2, CFTR]
GO:0019532;oxalate transport;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;53.14108600855652;7.292166977892469;0.0017785843248339678;0.769162383550154;[SLC26A8, SLC26A7, SLC26A3]
GO:0048194;Golgi vesicle budding;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;40.36515259490852;7.069023426578259;0.0013509853310727546;0.6846304993685643;[ATP8A1, GOLPH3L, ATP11C]
